| Kelly Rourke, | |
|
Kencrest Services, 502 W Germantown Pike, Suite 200, Plymouth Meeting, PA 19462 | |
| (610) 825-9360 | |
| (610) 825-2414 |
| Full Name | Kelly Rourke |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | Kencrest Services, Plymouth Meeting, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124243894 | NPI | - | NPPES |
| 1017297660001 | Other | PA | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SL008468 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Rourke, Kencrest Services, 502 W Germantown Pike, Suite 200, Plymouth Meeting, PA 19462 Ph: (610) 825-9360 | Kelly Rourke, Kencrest Services, 502 W Germantown Pike, Suite 200, Plymouth Meeting, PA 19462 Ph: (610) 825-9360 |
News Archive
Bbiotechnology company NEUROKIN, dedicated to the development of neuroprotective drugs to treat acute neurological diseases, announces today that the European Patent Office (EPO) has granted patent EP 1998778 protecting the use of NK-102, its most advanced drug candidate. This first European award constitutes an important milestone for NEUROKIN. An application for registration is under way in Brazil, Canada, China, USA and Japan.
Uganda this year plans to conduct a survey to determine the prevalence of multi-drug resistant tuberculosis in the country, National Leprosy and TB program manager Francis Adatu said Wednesday, the Monitor reports.
"The right to decide whether to have children, how many to have, and when to have them is a core human right for women everywhere, and having the option of a full range of contraceptive methods ensures that this right can be upheld," Pamela Barnes, president and CEO of EngenderHealth, writes in the Huffington Post's "Global Motherhood" blog.
An evaluation of the Public Health Grid (PHGrid) technology during the 2009 H1N1 influenza pandemic could enhance the capabilities of epidemiologists and disease-control agencies when the next emergent disease appears, according to a study published in the International Journal of Grid and Utility Computing.
› Verified 2 days ago
Meredith B. Horne, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd Ste 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 | |
Cherie Levy Roche, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462 Phone: 800-879-4471 | |
Burnetta Swartz, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Ste 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 | |
Mrs. Kristin Sears-kopp, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462 Phone: 800-879-4471 | |
Ms. Vicki Lynn Meitus, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 502 W Germantown Pike, Suite 200, Plymouth Meeting, PA 19462 Phone: 610-825-9360 | |
Ann Elizabeth Bollenbach, MED CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Road, Suite 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 Fax: 610-834-7525 | |
Mrs. Mila Marie Capuano, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Plymouth Meeting, PA 19462 Phone: 610-834-1122 |